Poland· PL-100160203

Prostamnic

A tamsulosin product containing tamsulosini hydrochloridum, registered in Poland by +pharma arzneimittel GmbH. The same ATC class is registered in 17 of our 19 countries.

ATC G04CA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedProstamnicATCG04CA02REGISTER NO.PL-100160203PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Tamsulosin is registered in 17 of 19 countries.

Countries holding a registration under ATC G04CA02 (tamsulosin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 11 of them publish a price we can compare per daily dose

Tamsulosin · ATC G04CA02

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tamsulosin costs, country by country.

Normalised to the WHO defined daily dose (0.4 mg), the median price runs from $0.17 in France to $1.11 in Switzerland — a ×6.5 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Tamsulosin · price per daily dose (0.4 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.11
  • ES Spain$0.42
  • IT Italy$0.25
  • FR France$0.17
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Tamsulosini hydrochloridum
Manufacturer
+pharma arzneimittel GmbH
Country
Poland (PL)
ATC code
G04CA02
ATC class
Tamsulosin
Defined daily dose
0.4 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

1 priced
  • gtin
    05909990573257
    30 szt.
    PLN 24.09
  • gtin
    05909990573264
  • gtin
    05901720140456

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

311 interactions on record for tamsulosin.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tamsulosin · interactions on record

311 records

  • 9 severe
  • 101 moderate
  • 1 minor
  • 168 info

Most severe, free to view

  • KetoconazoleH02CA03severe
  • ClarithromycinJ01FA09severe
  • KetoconazoleJ02AB02severe
  • Darunavir and cobicistatJ05AR14severe

32 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tamsulosin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tamsulosin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Aglandin Retard, Tamsu
  • Belgium · Omic Ocas, Ranomax
  • Bulgaria · Tamaliz, Омник Токас
  • Cyprus · Tamsulijn, Tamsulosin Aurobindo
  • Czechia · Fokusin, Lannatam
  • Germany · Omnic Ocas, Prostadil
  • Denmark · Bladasin, Miktosan
  • Estonia · Flosin, Omsal
  • Spain · Inreq, Omnic
  • Finland · Expros, Omnic Ocas
  • France · Mecir L.P., Omexel L.P.
  • United Kingdom (Northern Ireland) · Contiflo Xl, Cositam Xl
  • Greece · Omnic Τocas, Prosolvin
  • Croatia · Bazetham, Flosin
  • Hungary · Galebon, Omnic
  • Ireland · Omnexel, Tamnexyl Xl
  • Iceland · Tamsulosin Hydrochloride Synthon, Tamsulosin Medical
  • Italy · Antunes, Botam
  • Lithuania · Flosin, Fokusin
  • Luxembourg · Omic Ocas, Ranomax
  • Latvia · Fokusin, Tamsulosin Lannacher
  • Malta · Tamnic, Tamnic 400 Micrograms Modified-Release Capsules, Hard
  • Netherlands · Duktam, Omnic 0,4
  • Norway · Miktosan, Omnic
  • Portugal · Omnic, Sebrane Xr
  • Romania · Contiflo Mr, Fokusin
  • Sweden · Tamicten
  • Slovenia · Miktan, Omnic Ocas
  • Slovakia · Fokusin, Geroprostan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dae3e43e-3614-4924-826b-95a75f37adcc
GET /v1/drugs/dae3e43e-3614-4924-826b-95a75f37adcc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki o zmodyfikowanym uwalnianiu, twarde",
  "source": "urpl",
  "strength": "0,4 mg",
  "packaging": "05909990573257 ¦ Rp ¦ 32593\n30 kaps.\n05909990573264 ¦ Rp ¦ 32594\n60 kaps.\n05901720140456 ¦ Rp ¦ 134630\n90 kaps.",
  "substance": "Tamsulosini hydrochloridum 0.4 mg",
  "common_name": "Tamsulosini hydrochloridum",
  "pl_product_id": "100160203",
  "pozwolenie_nr": "12165",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}

See everything about tamsulosin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.